
Keywords: ACPA; anti-citrullinated protein antibodies; Anti-CarP; anti-carbamylated protein; CASPAR; Classification of psoriatic arthritis; CCP; cyclic citrullinated protein; DAS; Disease activity score; DMARD; disease modifying anti-rheumatic drug; FDA; US Food an